SITC's Surfaceome Workshop
Attend the SITC Interrogating the Tumor-Specific Surfaceome for Immune Targeting Workshop on April 23–24, 2020, in San Diego.
This workshop will provide an intimate opportunity for attendees to discuss their work with experts in the field. Abstracts are due by Friday, Feb. 28, at 5 p.m. PST. Encore presentations welcome!
Join Daniel Chen, MD, PhD, and the thousands of other cancer immunotherapy professionals who proudly call themselves SITC members.
SITC 2019 Quality Summit Consensus Report
Read the manuscript, Defining Current Gaps in Quality Measures for Cancer Immunotherapy: Consensus Report from the Society for Immunotherapy of Cancer (SITC) 2019 Quality Summit, as published in the Journal for ImmunoTherapy of Cancer.
Now Available: SITC Consensus Statement on Immunotherapy for the Treatment of Advanced Renal Cell Carcinoma
SITC Career ConnectionsConnecting talent seekers with job seekers at all career levels throughout the cancer immunotherapy field.
New Online Patient Course Available: Understanding Cancer Immunotherapy Access SITC’s dedicated resource for patients and caregivers to learn about cancer immunotherapy
NOW AVAILABLE: SITC's Guide to Managing Immunotherapy Toxicity A new handbook from SITC for clinicians providing thorough coverage of the toxicity and management of adverse events for immune checkpoint inhibitors.
ASCO-SITC Clinical Immuno-Oncology Symposium
Attend ASCO-SITC Clinical Immuno-Oncology Symposium Feb. 6–8, 2020, in Orlando, Fla. to learn across disease sites to solve the latest clinical challenges and understand the complexity of therapy sequencing in Immuno-Oncology.
IO360˚convenes stakeholders spanning the science and business communities to report on the latest data impacting immuno-oncology to fight a wider range of cancers. Attend the conference Feb. 26–28, 2020, in New York.
2020 Multidisciplinary Head and Neck Cancers SymposiumAttend the symposium Feb. 27–29, 2020, in Scottsdale, Ariz. This practical and interactive meeting is for the entire head and neck cancer care community.
6th Annual Immuno-Oncology Young Investigators' ForumAn academic research forum, April 16–18, 2020, in Houston, focusing on research and career development for Oncology junior faculty, fellows and postdoctoral researchers. Abstract submission deadline is Jan. 29, 2020.
Inspire the Next Generation of Cancer Immunotherapy Leaders
Advance the science of cancer immunotherapy and help young investigators tackle hurdles facing the field with a gift to the SITC Forward Fund.
Explore resources and educational opportunities for cancer patients and those who advocate for them.
Track the latest advancements and educational opportunities in cancer immunotherapy and immunology.
Advance science, submit your manuscript and monitor the global progress of cancer immunotherapy research.
Presentations from the 2019 Advances in Cancer Immunotherapy ™ – Boston, MA held on October 10, 2019 are now available in the SITC Resource Library. Click here to access ACI – Boston presentations. You can also reach these materials by clicking on ...
Thank you for attending the Advances in Cancer Immunotherapy™ program in San Diego, CA on December 12, 2019. We were pleased you could join us to take part in the education and networking opportunities this program provided.
As a benefit of attending ...
Presentations from the 2019 Advances in Cancer Immunotherapy ™ – Chicago, IL held on September 28, 2019 are now available in the SITC Resource Library. Click here to access ACI – Chicago presentations. You can also reach these materials by clicking ...
Donate today to support early career scientists who are emerging leaders seeking to advance research in the cancer immunotherapy field.
An open access, peer-reviewed journal, the Journal for ImmunoTherapy of Cancer (JITC) is the global voice of the society, producing original research articles, literature reviews and more on tumor immunology and cancer immunotherapy.
It is the mission of the Society for Immunotherapy of Cancer (SITC) to improve cancer patient outcomes by advancing the science, development and application of cancer immunology and immunotherapy through our core values of interaction/integration, innovation, translation and leadership in the field. SITC aims to make cancer immunotherapy a standard of care and the word “cure” a reality for cancer patients everywhere.
Tel: +1 414 271 2456 | Fax: +1 414 276 3349 | Email: email@example.com